Active: new deal Jul 2026 Verified 5 Nov 2026
MBX Capital
MBX Capital is an early-stage venture firm backing biotech and life sciences founders across therapeutics, diagnostics, tools, AI for biology and chemistry. Based in Tuxedo Park, NY.
- Type
- VC firm
- Location
- Tuxedo Park, New York, United States
- Stages
- Seed
- Backs
- Biotech and pharma, Medtech and digital health
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- $50M Mbx Capital III (Form D offering, 2023); $94.7M gross private fund assets (Form ADV; private funds: 45, of which venture capital: 45)
- Website
- mbxcapital.com
Contacts on file
For MBX Capital, the paid file holds: 2 named decision-makers with roles; firm contact email (domain checked).
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
OpentronsVivodyneEarliContralineJuniper Genomics
Sources
- adviserinfo.sec.gov/firm/summary/312079
- mbxcapital.com/
- www.sec.gov/Archives/edgar/data/1982917/000198291723000001/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 21 lists
Biotech investors in New York (29)Medtech investors in New York (53)Healthtech investors in New York (100)Seed investors in New York (128)Seed biotech investors in the US (159)Seed medtech investors in the US (205)Seed medtech investors (278)Biotech venture capital firms in the US (297)Seed biotech investors (300)Medtech venture capital firms in the US (350)Seed healthtech investors in the US (437)Venture capital firms in New York (440)Medtech investors (457)Biotech investors (484)Healthtech venture capital firms in the US (709)Seed healthtech investors (800)Seed investors in the US (1,043)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Seed investors (1,892)Venture capital firms in the US (2,975)